Denmark has stopped the usage of the AstraZeneca Covid-19 vaccine. (Picture: John Beckmann/BSR Company/Getty Pictures)
- Denmark has stopped the usage of AstraZeneca’s Covid-19 vaccine fully after doable hyperlinks to very uncommon blood clot circumstances had been discovered.
- As of 4 April, the European Medicines Company had acquired studies of 169 circumstances of CVST after 34 million AstraZeneca doses had been administered within the European Financial Space.
- Denmark has additionally put Johnson & Johnson’s vaccine on pause pending additional investigations right into a doable comparable blood clot hyperlink.
Denmark on Wednesday turned the primary nation to cease utilizing AstraZeneca’s Covid-19 vaccine altogether, following information of its doable hyperlink to very uncommon blood clot circumstances, well being authorities mentioned.
The choice will push again the scheduled conclusion of Denmark’s vaccination scheme to early August from 25 July, they mentioned.
Outcomes of investigations into the blood clots “confirmed actual and critical uncomfortable side effects,” well being company head Soren Brostrom mentioned in a press release.
“Based mostly on an total consideration, we have now due to this fact chosen to proceed the vaccination programme for all goal teams with out this vaccine”.
The European Union’s drug watchdog mentioned final week it had discovered a doable hyperlink between the AstraZeneca vaccine and cerebral venous sinus thrombosis (CVST), a mind blood clot, however mentioned the chance of dying from Covid-19 was “a lot better” than the chance of mortality from uncommon uncomfortable side effects.
As of 4 April, the European Medicines Company had acquired studies of 169 circumstances of CVST after 34 million Astrazeneca doses had been administered within the European Financial Space.
The EU regulator, nevertheless, left it to particular person states to make their very own threat assessments and determine methods to administer the vaccine.
Many international locations in Europe and elsewhere have resumed administering the shot, with some limiting its use to sure age teams, largely these aged above 50 or above 60.
Denmark was the primary nation to initially droop all utilization of the vaccine in March over security issues, and has additionally put Johnson & Johnson’s vaccine on pause pending additional investigations right into a doable comparable blood clot hyperlink.
Virtually a million of the nation’s 5.8 million inhabitants have acquired their first pictures, 77% getting Pfizer-BioNTech’s vaccine, 7.8% Moderna’s and 15.3% AstraZeneca’s.
Denmark is within the technique of easing restrictions after its day by day Covid-19 an infection price slowed to 500-600 from a number of thousand in December.